Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan.
Graduate Institute of Public Health, China Medical University, Taichung, Taiwan.
Int J Clin Pract. 2021 Jun;75(6):e14126. doi: 10.1111/ijcp.14126. Epub 2021 Mar 17.
Pneumococcal disease poses a burden to the community in high risk population. Most early studies focused on invasive pneumococcal disease. However, the epidemiology of pneumococcal pneumonia (PP) requiring hospitalisation in solid organ transplant recipients (SOTRs) is poorly defined.
We conducted a retrospective cohort study (January 1, 2000 and December 31, 2012) to evaluate the risk of PP requiring hospitalisation in SOTRs. SOTRs and non-SOT cohorts, propensity score-matched at a 1:1 ratio for age, sex, index date and underlying comorbidities, were identified from the National Health Insurance Research Database.
Each cohort consisted of 7507 patients. In the SOT cohort, 26 episodes of PP requiring hospitalisation were identified (incidence rate of 52.4 per 100,000 person-years). The risk of PP requiring hospitalisation in the SOT cohort was 1.50 times greater than in the non-SOT cohort [adjusted hazard ratio: 1.50, 95% confidence interval = 1.31-1.71, P < .001]. The nested case control study identified older age, kidney transplant, and concomitant chronic obstructive pulmonary disease, chronic kidney disease and heart failure as predictors of PP requiring hospitalisation in the SOT cohort. The highest risk period for PP requiring hospitalisation occurred within the first year of transplantation (36.47 per 1000 patients). Amongst kidney transplant recipients, patients with PP requiring hospitalisation exhibited higher cumulative incidences of graft failure than those without PP (log-rank test: P value = .004).
SOTRs are at risk of PP requiring hospitalisation with its attendant morbidity. Strategies to reduce risk of PP requiring hospitalisation using preventive vaccinations warrant further study.
肺炎球菌疾病给高危人群的社区带来了负担。大多数早期研究都集中在侵袭性肺炎球菌疾病上。然而,实体器官移植受者(SOTR)需要住院治疗的肺炎球菌性肺炎(PP)的流行病学尚未得到明确界定。
我们进行了一项回顾性队列研究(2000 年 1 月 1 日至 2012 年 12 月 31 日),以评估 SOTR 中需要住院治疗的 PP 的风险。从国家健康保险研究数据库中确定了 SOT 队列和非 SOT 队列,这些队列按年龄、性别、索引日期和基础合并症进行了 1:1 的倾向评分匹配。
每个队列都包含 7507 名患者。在 SOT 队列中,发现了 26 例需要住院治疗的 PP 病例(发病率为 52.4/100,000 人年)。SOT 队列中需要住院治疗的 PP 风险是非 SOT 队列的 1.50 倍[调整后的危险比:1.50,95%置信区间为 1.31-1.71,P<.001]。嵌套病例对照研究确定了年龄较大、肾移植以及同时患有慢性阻塞性肺疾病、慢性肾脏病和心力衰竭是 SOT 队列中需要住院治疗的 PP 的预测因素。需要住院治疗的 PP 的最高风险期发生在移植后的第一年(36.47/1000 例患者)。在肾移植受者中,需要住院治疗的 PP 患者的移植物失功累积发生率高于无 PP 患者(对数秩检验:P 值<.001)。
SOTR 需要住院治疗的 PP 风险及其伴随的发病率较高。使用预防性疫苗降低需要住院治疗的 PP 风险的策略值得进一步研究。